Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection

2019 ◽  
Vol 35 (5) ◽  
pp. 855-861 ◽  
Author(s):  
Hidenori Toyoda ◽  
Masanori Atsukawa ◽  
Tsunamasa Watanabe ◽  
Makoto Nakamuta ◽  
Haruki Uojima ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document